Harmony Biosciences Holdings Inc
HRMY
Market Cap$1.67B
Close$
Share Statistics
| Market cap | $1.67 Billion |
|---|---|
| Enterprise Value | $1.51 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $2.13 |
| Beta | 0.0 |
| Outstanding Shares | 56,791,214 |
| Avg 30 Day Volume | 389,212 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 12.92 |
|---|---|
| PEG | -28.62 |
| Price to Sales | 2.93 |
| Price to Book Ratio | 3.66 |
| Enterprise Value to Revenue | 2.59 |
| Enterprise Value to EBIT | 7.84 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.41 |
Revenue Sources
No data
ESG Score
No data
About Harmony Biosciences Holdings Inc
150 employeesHarmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.